1362 related articles for article (PubMed ID: 26937141)
41. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
[TBL] [Abstract][Full Text] [Related]
42. Dietary Fatty Acid Regulation of the NLRP3 Inflammasome via the TLR4/NF-
Jin X; Dong X; Sun Y; Liu Z; Liu L; Gu H
Oxid Med Cell Longev; 2022; 2022():3711371. PubMed ID: 35571243
[TBL] [Abstract][Full Text] [Related]
43. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin.
Yang W; Liu L; Wei Y; Fang C; Liu S; Zhou F; Li Y; Zhao G; Guo Z; Luo Y; Li L
Lab Invest; 2021 Mar; 101(3):369-380. PubMed ID: 33268842
[TBL] [Abstract][Full Text] [Related]
44. Nod-like receptor protein 3 inflammasome activation by Escherichia coli RNA induces transforming growth factor beta 1 secretion in hepatic stellate cells.
Wang H; Liu S; Wang Y; Chang B; Wang B
Bosn J Basic Med Sci; 2016 Jan; 16(2):126-31. PubMed ID: 26773180
[TBL] [Abstract][Full Text] [Related]
45. Palmitic acid activates NLRP3 inflammasome through NF-κB and AMPK-mitophagy-ROS pathways to induce IL-1β production in large yellow croaker (Larimichthys crocea).
Li X; Mai K; Ai Q
Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Mar; 1869(2):159428. PubMed ID: 38029958
[TBL] [Abstract][Full Text] [Related]
46. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
[TBL] [Abstract][Full Text] [Related]
47. MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line.
Luo M; Hu L; Li D; Wang Y; He Y; Zhu L; Ren W
Mol Immunol; 2017 Oct; 90():1-10. PubMed ID: 28654770
[TBL] [Abstract][Full Text] [Related]
48. CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in mice.
Qi J; Yan X; Li L; Qiu K; Huang W; Zhou Z
Int Immunopharmacol; 2023 Oct; 123():110752. PubMed ID: 37573690
[TBL] [Abstract][Full Text] [Related]
49. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
[TBL] [Abstract][Full Text] [Related]
50. NZ suppresses TLR4/NF-κB signalings and NLRP3 inflammasome activation in LPS-induced RAW264.7 macrophages.
Xiang P; Chen T; Mou Y; Wu H; Xie P; Lu G; Gong X; Hu Q; Zhang Y; Ji H
Inflamm Res; 2015 Oct; 64(10):799-808. PubMed ID: 26298161
[TBL] [Abstract][Full Text] [Related]
51. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
[TBL] [Abstract][Full Text] [Related]
52. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
[TBL] [Abstract][Full Text] [Related]
53. NF-κB Blockade in Hypothalamic Paraventricular Nucleus Inhibits High-Salt-Induced Hypertension Through NLRP3 and Caspase-1.
Qi J; Yu XJ; Shi XL; Gao HL; Yi QY; Tan H; Fan XY; Zhang Y; Song XA; Cui W; Liu JJ; Kang YM
Cardiovasc Toxicol; 2016 Oct; 16(4):345-54. PubMed ID: 26438340
[TBL] [Abstract][Full Text] [Related]
54. Sini powder ameliorates the inflammatory response in rats with stress-induced non-alcoholic fatty liver disease by inhibiting the nuclear factor kappa-B / pyrin domain-containing protein 3 pathway.
Mu J; Cheng F; Wang Q; Wang X; Zhu W; Ma C; Yin X; Ren B; Lian Y; Du X; Zhang H; Liu S; Zhang S
J Tradit Chin Med; 2020 Apr; 40(2):253-266. PubMed ID: 32242391
[TBL] [Abstract][Full Text] [Related]
55. RNA adenosine deaminase (ADAR1) alleviates high-fat diet-induced nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome.
Xiang R; Liu Y; Fan L; Jiang B; Wang F
Lab Invest; 2022 Oct; 102(10):1088-1100. PubMed ID: 35690649
[TBL] [Abstract][Full Text] [Related]
56. Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis.
Zhang NP; Liu XJ; Xie L; Shen XZ; Wu J
Lab Invest; 2019 Jun; 99(6):749-763. PubMed ID: 30700851
[TBL] [Abstract][Full Text] [Related]
57. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
58. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
[TBL] [Abstract][Full Text] [Related]
59. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation.
Wang L; Wang Y; Wang Z; Qi Y; Zong B; Liu M; Li X; Zhang X; Liu C; Cao R; Ma Y
Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G909-G920. PubMed ID: 30188752
[TBL] [Abstract][Full Text] [Related]
60. High Glucose-Aggravated Hepatic Insulin Resistance: Role of the NLRP3 Inflammasome in Kupffer Cells.
Zheng T; Wang Q; Dong Y; Ma W; Zhang Y; Zhao Y; Bian F; Chen L
Obesity (Silver Spring); 2020 Jul; 28(7):1270-1282. PubMed ID: 32538511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
